The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow COO
The Cooper Companies, Inc. (COO) Revenue
The Cooper Companies, Inc.'s revenue for fiscal 2025 was $4.1B, up 5.06% from $3.9B in fiscal 2024. Over the twelve months to 31 July 2026 it was $4.2B. Over the past ten years it has ranged from $1.8B (fiscal 2015) to $4.1B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 5 consecutive fiscal years. The Cooper Companies, Inc. ranks 10th of 50 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $4.1B | 5.06% |
| FY2024 | $3.9B | 8.41% |
| FY2023 | $3.6B | 8.61% |
| FY2022 | $3.3B | 13.20% |
| FY2021 | $2.9B | 20.22% |
| FY2020 | $2.4B | (8.39%) |
| FY2019 | $2.7B | 4.76% |
| FY2018 | $2.5B | 18.41% |
| FY2017 | $2.1B | 8.76% |
| FY2016 | $2.0B | 9.44% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jul 2026 | $1.1B | (1.41%) |
| Apr 2026 | $1.1B | 5.60% |
| Jan 2026 | $1.0B | (3.85%) |
| Oct 2025 | $1.1B | 0.45% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| BAX Baxter International Inc. compare | $11.5B |
| SOLV Solventum Corporation compare | $8.3B |
| AVTR Avantor, Inc. compare | $6.6B |
| BLCO Bausch + Lomb Corporation compare | $5.3B |
| COO The Cooper Companies, Inc. | $4.2B |
| ALGN Align Technology, Inc. compare | $4.1B |
| ATR AptarGroup, Inc. compare | $3.9B |
| TFX Teleflex Incorporated compare | $2.3B |
| RGEN Repligen Corporation compare | $785.1M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on COO
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement